NCT06395428

Haloperidol for Pain Control in Patients With Acute Musculoskeletal Back Pain in the Emergency Department

• Status: Recruiting
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 75 (estimated)
• Sponsor: Western Michigan University School of Medicine · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

Single center, double-blind, randomized, controlled trial in patients who present to the emergency department (ED) with a chief complaint of back pain. A total of 150 patients age 18-65 presenting to the emergency department with chief complaint of backpain will be enrolled from April 2024 - April 2025. Patients will be randomized and symptom levels will be recorded at 30, 60, 90, minutes. Follow-up will be performed by telephone at 24 hours.

Conditions

• Back Pain
• Chronic Pain

Interventions

Type	Name	Description
DRUG	Haloperidol	Intramuscular injection of drug
DRUG	Ketorolac Tromethamine	Intramuscular injection of drug

Timeline

• Start date: 2024-07-09
• Primary completion: 2025-04-15
• Completion: 2027-04-15
• First posted: 2024-05-02
• Last updated: 2024-07-10

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study